LONDON (Alliance News) - Biopharmaceutical company Hutchison China MediTech Ltd said Monday patients in its FRESCO Phase III study "demonstrated a statistically significant and clinically at Read More
LONDON (Alliance News) - China-focused drug developer and distributor Hutchison China Meditech PLC said Monday annual losses widened due to increased and Read More
LONDON (Alliance News) - Pharmaceutical firm Hutchison China Meditech Ltd has started a phase Ib/II proof-of-concept study for its proposed brain cancer treatment is being in Read More
